补体第六成分（C6）缺乏的家兔的血液凝固异常及其通过纯化的C6的纠正。
A blood coagulation abnormality in rabbits deficient in the sixth component of complement (C6) and its correction by purified C6.
作者信息
Zimmerman T S, Arroyove C M, Müller-Eberhard H J
出版信息
J Exp Med. 1971 Dec 1;134(6):1591-600. doi: 10.1084/jem.134.6.1591.
Abstract
Evidence for the involvement of the sixth component of complement (C6) in normal blood coagulation is provided by the description of a coagulation abnormality in rabbits with a genetic C6 deficiency and by its correction with highly purified preparations of C6. Whole blood clotting time in glass or plastic was prolonged and prothrombin consumption was decreased in blood from the deficient animals. Other parameters of blood coagulation were normal, including prothrombin time, partial thromboplastin time, specific clotting factor activities, platelet factor III function, platelet count, and bleeding time. Clotting time and prothrombin consumption became normal when physiologic amounts of highly purified C6 were added to the deficient blood. Partial consumption of C6 hemolytic activity, with a time course similar to the consumption of prothrombin, was demonstrated during the clotting of normal human blood.
摘要
遗传性C6缺乏的兔子出现凝血异常，并通过用高度纯化的C6制剂纠正该异常，从而证明补体第六成分（C6）参与正常血液凝固。缺乏C6的动物血液在玻璃或塑料中全血凝固时间延长，凝血酶原消耗减少。血液凝固的其他参数正常，包括凝血酶原时间、部分凝血活酶时间、特定凝血因子活性、血小板因子III功能、血小板计数和出血时间。当向缺乏C6的血液中添加生理量的高度纯化C6时，凝固时间和凝血酶原消耗恢复正常。在正常人血液凝固过程中，C6溶血活性出现部分消耗，其时间进程与凝血酶原的消耗相似。
相似文献
1
A blood coagulation abnormality in rabbits deficient in the sixth component of complement (C6) and its correction by purified C6.补体第六成分（C6）缺乏的家兔的血液凝固异常及其通过纯化的C6的纠正。
J Exp Med. 1971 Dec 1;134(6):1591-600. doi: 10.1084/jem.134.6.1591.
2
Hereditary deficiency of the sixth component of complement in man. II. Studies of hemostasis.人类补体第六成分的遗传性缺陷。II. 止血研究。
J Clin Invest. 1974 Feb;53(2):554-8. doi: 10.1172/JCI107589.
3
Blood coagulation initiation by a complement-mediated pathway.补体介导途径引发血液凝固。
J Exp Med. 1971 Dec 1;134(6):1601-7. doi: 10.1084/jem.134.6.1601.
4
Hereditary C6 deficiency in man.人类遗传性C6缺乏症。
Birth Defects Orig Artic Ser. 1975;11(1):318-21.
5
Effects of endotoxin in cortisone-treated rabbits with a hereditary deficiency of the sixth component of complement (C6 deficiency).内毒素对补体第六成分遗传性缺乏（C6缺乏）的经可的松治疗的家兔的影响。
Thromb Haemost. 1976 Apr 30;35(2):460-71.
6
Congenital and experimentally induced complement deficiency in rabbits.兔子的先天性及实验性诱导补体缺乏
Birth Defects Orig Artic Ser. 1975;11(1):571-6.
7
COAGULATION AND FIBRINOLYSIS IN INJURED PATIENTS.受伤患者的凝血与纤维蛋白溶解
J Clin Pathol. 1964 Jan;17(1):1-13. doi: 10.1136/jcp.17.1.1.
8
Combined hereditary deficiency of the sixth component of complement and factor VIII coagulant activity in a Dutch family.荷兰一个家族中补体第六成分和凝血因子 VIII 凝血活性的联合遗传性缺乏。
Clin Exp Immunol. 1982 Jun;48(3):733-8.
9
The role of complement in endotoxin-induced disseminated intravascular coagulation: studies in congenitally C6-deficient rabbits.补体在内毒素诱导的弥散性血管内凝血中的作用：对先天性C6缺乏兔的研究
Br J Haematol. 1974 Nov;28(3):403-18. doi: 10.1111/j.1365-2141.1974.tb00821.x.
10
Abnormal platelet response to thromboplastin infusion in rabbits deficient in the sixth component of complement.补体第六成分缺乏的家兔对凝血活酶输注的血小板异常反应。
Proc Soc Exp Biol Med. 1974 Jul;146(3):732-7. doi: 10.3181/00379727-146-38182.
引用本文的文献
1
Complement component 5 does not interfere with physiological hemostasis but is essential for Escherichia coli-induced coagulation accompanied by Toll-like receptor 4.补体成分 5 不干扰生理止血，但对于伴随 Toll 样受体 4 的大肠杆菌诱导的凝血是必需的。
Clin Exp Immunol. 2019 Apr;196(1):97-110. doi: 10.1111/cei.13240. Epub 2018 Dec 19.
2
Abnormal platelet function in C3-deficient mice.C3缺陷小鼠的血小板功能异常。
J Thromb Haemost. 2009 May;7(5):865-70. doi: 10.1111/j.1538-7836.2009.03334.x. Epub 2009 Mar 5.
3
Hereditary deficiency of the sixth component of complement in man. II. Studies of hemostasis.人类补体第六成分的遗传性缺陷。II. 止血研究。
J Clin Invest. 1974 Feb;53(2):554-8. doi: 10.1172/JCI107589.
4
Hereditary deficiency of the sixth component of complement in man. I. Immunochemical, biologic, and family studies.人类补体第六成分的遗传性缺陷。I. 免疫化学、生物学及家系研究。
J Clin Invest. 1974 Feb;53(2):544-53. doi: 10.1172/JCI107588.
5
6
Combined hereditary deficiency of the sixth component of complement and factor VIII coagulant activity in a Dutch family.荷兰一个家族中补体第六成分和凝血因子 VIII 凝血活性的联合遗传性缺乏。
Clin Exp Immunol. 1982 Jun;48(3):733-8.
7
Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit.终末补体途径在兔实验性膜性肾病中的作用
J Clin Invest. 1983 Dec;72(6):1948-57. doi: 10.1172/JCI111159.
8
Relationships among the complement, kinin, coagulation, and fibrinolytic systems.补体、激肽、凝血和纤溶系统之间的关系。
Springer Semin Immunopathol. 1983;6(2-3):231-58. doi: 10.1007/BF00205875.
9
Blood coagulation initiation by a complement-mediated pathway.补体介导途径引发血液凝固。
J Exp Med. 1971 Dec 1;134(6):1601-7. doi: 10.1084/jem.134.6.1601.
10
Activation of the alternate complement pathway by autologous red cell stroma.自体红细胞基质激活替代补体途径。
J Exp Med. 1973 Sep 1;138(3):715-22. doi: 10.1084/jem.138.3.715.
本文引用的文献
1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
A simple, specific one-stage prothrombin assay using Russell's viper venom in cephalin suspension.一种在脑磷脂悬浮液中使用罗素蝰蛇毒的简单、特异的一步法凝血酶原测定法。
J Lab Clin Med. 1955 Jul;46(1):89-97.
3
STUDIES ON PLATELET FACTOR-3 AVAILABILITY.血小板第3因子有效性的研究。
Br J Haematol. 1965 May;11:269-75. doi: 10.1111/j.1365-2141.1965.tb06587.x.
4
DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.圆盘电泳。II. 方法及其在人血清蛋白中的应用。
Ann N Y Acad Sci. 1964 Dec 28;121:404-27. doi: 10.1111/j.1749-6632.1964.tb14213.x.
5
EFFECT OF ADENOSINE NUCLEOTIDES ON PLATELET AGGREGATION AND CLOTTING TIME.腺苷核苷酸对血小板聚集和凝血时间的影响。
J Lab Clin Med. 1964 Oct;64:548-59.
6
The purification of activated Hageman factor (activated factor XII).活化的哈格曼因子（活化的因子XII）的纯化。
Biochemistry. 1962 Nov;1:967-75. doi: 10.1021/bi00912a005.
7
An effect of antigen-antibody interaction on blood coagulation.抗原-抗体相互作用对血液凝固的影响。
J Exp Med. 1959 Jan 1;109(1):1-8. doi: 10.1084/jem.109.1.1.
8
The preparation of proaccelerin deficient (parahemophilia) plasma for the assay of proaccelerin.用于促凝血加速素测定的促凝血加速素缺乏（副血友病）血浆的制备。
Scand J Clin Lab Invest. 1957;9(3):273-6. doi: 10.3109/00365515709079970.
9
A modification of the thromboplastin generation test.凝血活酶生成试验的一种改良方法。
Acta Haematol. 1954 Sep;12(3):197-202. doi: 10.1159/000204619.
10
An accelerating property of plasma for the coagulation of fibrinogen by thrombin.血浆对凝血酶使纤维蛋白原凝固的促进作用。
J Clin Invest. 1954 Aug;33(8):1175-82. doi: 10.1172/JCI102990.
Zotero 插件